| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 12/29/2009 | US7638121 Preparing human recipient for graft; administer to individual irradiated thymocytes, CD-2 monoclonal antibody, donor peripheral blood progenitor and immunosuppressants; monitor for transplant rejection |
| 12/29/2009 | CA2247522C Iscom or iscom-matrix comprising a mucus targetting substance and optionally, an antigen |
| 12/29/2009 | CA2189848C Photocleavable agents and conjugates for the detection and isolation of biomolecules |
| 12/24/2009 | US20090318360 Use of the neurotoxic component of a botulinum toxin for treating arthritis |
| 12/24/2009 | US20090318337 Compositions and methods for activating innate and allergic immunity |
| 12/24/2009 | US20090317480 Chimeric immunomodulatory compounds and methods of using the same-ii |
| 12/24/2009 | US20090317475 Combination antitumor therapies |
| 12/24/2009 | US20090317456 Use of oncolytic viruses and antiangiogenic agents in the treatment of cancer |
| 12/24/2009 | US20090317428 Immunogenic T-Helper Epitopes From Human Tumour Antigens and Immunotherapeutic Methods Using Said Epitopes |
| 12/24/2009 | US20090317427 Zwitterionic Polysaccharides for Promotion of Immune System Maturation and Health |
| 12/24/2009 | US20090317426 Method for treating knee joint pain caused by saphenous nerve entrapment |
| 12/24/2009 | US20090317425 Refrigerator-temperature stable influenza vaccine compositions |
| 12/24/2009 | US20090317424 Oral vaccines |
| 12/24/2009 | US20090317423 Pcv2 mycoplasma hyopneumoniae immunogenic compositions and methods of producing such compositions |
| 12/24/2009 | US20090317422 Use of ppd for the adjuvantation of a nucleic acid vaccine |
| 12/24/2009 | US20090317421 Compositions and methods related to staphylococcal bacterium proteins |
| 12/24/2009 | US20090317420 Immunogenic compositions for gram positive bacteria such as streptococcus agalactiae |
| 12/24/2009 | US20090317419 Tetramers |
| 12/24/2009 | US20090317418 Vaccines and methods for prevention and treatment of drug-resistant hiv-1 and hepatitis b virus |
| 12/24/2009 | US20090317417 Modified AAV Vectors Having Reduced Capsid Immunogenicity and Use Thereof |
| 12/24/2009 | US20090317416 Antibodies, vaccines, tumor antigens |
| 12/24/2009 | US20090317415 Hpv vaccine comprising peptides from host cell proteins |
| 12/24/2009 | US20090317414 Cancer vaccine comprising a mucin 1 (muc1) t cell epitope-derived peptide |
| 12/24/2009 | US20090317413 Detection of human platelet antigen (hpa) antibodies |
| 12/24/2009 | US20090317412 Induction of an immune response against streptococcus pneumoniae polyaccharides |
| 12/24/2009 | US20090317411 Compositions for inducing immune responses specific to globo h and ssea3 and uses thereof in cancer treatment |
| 12/24/2009 | US20090317410 Use of zwitterionic polysaccharides for the specific modulation of immune processes |
| 12/24/2009 | US20090317409 Antibodies for ubiquitinated proteins |
| 12/24/2009 | US20090317408 Ligand conjugated thermotherapy susceptors and methods for preparing same |
| 12/24/2009 | US20090317407 Augmentation of immune response to cancer vaccine |
| 12/24/2009 | US20090317406 Phosphorylation of tau by abl |
| 12/24/2009 | US20090317405 Antibody and uses thereof |
| 12/24/2009 | US20090317404 Reduction and prevention of cell-associated hiv transepithelial migration, microbides and other formulations and methods |
| 12/24/2009 | US20090317403 Use of CSF-1 Inhibitors |
| 12/24/2009 | US20090317402 Antibodies to il-6 and their uses |
| 12/24/2009 | US20090317401 Angiogenic and immunoglobic applications of anti cd160 specific compounds obtainable from mab cl 1-r2 |
| 12/24/2009 | US20090317400 Anti-IL 17A/IL-17F Cross-Reactive Antibodies and Methods of Use Thereof |
| 12/24/2009 | US20090317399 Uses and compositions for treatment of CROHN'S disease |
| 12/24/2009 | US20090317398 a labeled polyclonal antibody, monoclonal antibody or antigen-binding fragment which preferentially binds to a polypeptide that chemoattracts peripheral blood monocytes or T-cells; proteins which control development, differentiation, trafficking and physiology of mammalian cells; immunology |
| 12/24/2009 | US20090317397 Soluble CTLA4 mutant molecules and uses thereof |
| 12/24/2009 | US20090317396 Antibody specifically binding to dr5 and composition for preventing or treating cancers comprising the same |
| 12/24/2009 | US20090317395 Antimicrobial Peptide Derived from Galanin Message Associated Peptide (GMAP) |
| 12/24/2009 | US20090317394 Vascular endothelial growth factor-2 |
| 12/24/2009 | US20090317393 Method of modifying glucose activity using polypeptides selectively expressed in fat tissue |
| 12/24/2009 | US20090317392 Method of diagnosing small cell lung cancer |
| 12/24/2009 | US20090317391 Cancer Related Genes (PTPE) |
| 12/24/2009 | US20090317390 Novel tissue factor targeted antibodies as anticoagulants |
| 12/24/2009 | US20090317389 Fusion molecules and methods for treatment of immune diseases |
| 12/24/2009 | US20090317388 Tl1a in treatment of disease |
| 12/24/2009 | US20090317387 Treatment of metastatic breast cancer |
| 12/24/2009 | US20090317386 Transcription Infidelity, Detection and Uses Thereof |
| 12/24/2009 | US20090317385 Methods Using Immunomodulatory Compounds for Modulating Level of CD59 |
| 12/24/2009 | US20090317384 Methods of using death receptor ligands and cd20 antibodies |
| 12/24/2009 | US20090317383 Cancer treatment method |
| 12/24/2009 | US20090317382 Use of effector-function-deficient antibodies for treatment of auto-immune diseases |
| 12/24/2009 | US20090317381 Clearance of abnormal iga1 in iga1 deposition diseases |
| 12/24/2009 | US20090317380 Use of prion conversion modulating agents |
| 12/24/2009 | US20090317379 Autophilic antibodies and method of making the same |
| 12/24/2009 | US20090317378 Antimicrobial composition and uses thereof |
| 12/24/2009 | US20090317377 Therapy procedure for drug delivery for trigeminal pain |
| 12/24/2009 | US20090317376 Compositions And Methods For Lipo Modeling |
| 12/24/2009 | US20090317359 2,6-disubstituted quinazolines, quinoxalines, quinolines and isoquinolines and methods of their use as inhibitors of raf kinase |
| 12/24/2009 | US20090317358 Chimeric proteins with cell-targeting specificity and apoptosis-inducing activities |
| 12/24/2009 | US20090317357 Methods for treating or preventing autoimmune disease using histamine h1 receptor-blocking agents |
| 12/24/2009 | US20090317329 Anticoagulation agent and uses thereof |
| 12/24/2009 | US20090317324 Filamentous bacteriophage displaying protein as a binder of antibodies and immunocomplexes for delivery to the brain |
| 12/23/2009 | WO2009155609A1 IMMUNOGENIC MEMAPSIN 2 β-SECRETASE PEPTIDES AND METHODS OF USE |
| 12/23/2009 | WO2009155535A2 Compositions, methods and kits for eliciting an immune response |
| 12/23/2009 | WO2009155513A2 Immunoglobulins with reduced aggregation |
| 12/23/2009 | WO2009155504A2 Methods for the modulation of angiogenesis |
| 12/23/2009 | WO2009155489A2 Compositions and methods for treating influenza |
| 12/23/2009 | WO2009155484A2 Compositions and methods of use of orf1358 from beta-hemolytic streptococcal strains |
| 12/23/2009 | WO2009155476A2 Compositions and methods of use of orf 554 from beta hemolytic streptococcal strains |
| 12/23/2009 | WO2009155180A1 Antibodies to il-6 and their uses |
| 12/23/2009 | WO2009154697A2 Disc-1 pathway activators in the control of neurogenesis |
| 12/23/2009 | WO2009154610A1 Immune regulatory oligonucleotide (iro) compounds to modulate toll-like receptor based immune response |
| 12/23/2009 | WO2009154565A1 Combination therapies against cancer |
| 12/23/2009 | WO2009154452A1 Parvoviral capsid with incorporated Gly-Ala repeat region |
| 12/23/2009 | WO2009154026A1 Antibody against calcified globule and use of the same |
| 12/23/2009 | WO2009153992A1 Cdca1 epitope peptides and vaccines containing the same |
| 12/23/2009 | WO2009153801A1 Dna vaccine based on glycoprotein gene of rabies virus conjugated to lamp-1 signal sequence at the c-terminus and an adjuvant; and method of its preparation thereof |
| 12/23/2009 | WO2009153518A2 Novel fusion proteins and use thereof for preparing hepatitis c vaccines |
| 12/23/2009 | WO2009153463A1 Immunogenic peptides derived from the midkine protein, as an anticancer vaccine |
| 12/23/2009 | WO2009153414A1 Modified beta-lactoglobulins for immunotherapy of milk allergy |
| 12/23/2009 | WO2009153337A1 Infection inhibitor |
| 12/23/2009 | WO2009153029A1 Anti-prion protein antibody fragment |
| 12/23/2009 | WO2009152986A1 Muc16 fragments with antigenic activity and pharmaceutical compositions thereof |
| 12/23/2009 | WO2009152969A1 Recombinant modified vaccinia virus measles vaccine |
| 12/23/2009 | WO2009152939A1 Biomarker for selecting patients and related methods |
| 12/23/2009 | WO2009152901A1 Methods for treatment of malignancies |
| 12/23/2009 | WO2009152783A1 Inhibitors of the epidermal growth factor receptor (egfr) with cytostatic action and their uses in tumour therapy |
| 12/23/2009 | WO2009134776A3 Dual variable domain immunoglobulins and uses thereof |
| 12/23/2009 | WO2009134401A3 Methods of inhibiting infection by diverse subtypes of drug-resistant hiv-1 |
| 12/23/2009 | WO2009133378A3 Products and methods for stimulating an immune response |
| 12/23/2009 | WO2009130256A3 Tat protein for preventing or treating aids |
| 12/23/2009 | WO2009129502A3 Immunotherapies employing self-assembling vaccines |
| 12/23/2009 | WO2009129498A3 Substance p and analogs thereof as a cancer immunogenic composition adjuvant |
| 12/23/2009 | WO2009126817A3 Ige antibodies for the treatment of cancer |
| 12/23/2009 | WO2009120659A3 Human monoclonal antibodies against amyloid beta protein, and their use as therapeutic agents |
| 12/23/2009 | WO2009114816A3 Therapeutic cancer antigens |